120 related articles for article (PubMed ID: 31966461)
1. SOX7 expression correlates with better prognosis in pancreatic cancer patients and is negatively related to pancreatic cancer associated diabetes.
Zhou L; Kang M
Int J Clin Exp Pathol; 2017; 10(11):11122-11129. PubMed ID: 31966461
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance and prognostic value of SOX7 expression in liver and pancreatic carcinoma.
Wang J; Zhang S; Wu J; Lu Z; Yang J; Wu H; Chen H; Lin B; Cao T
Mol Med Rep; 2017 Jul; 16(1):499-506. PubMed ID: 28586005
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
Cui J; Xi H; Cai A; Bian S; Wei B; Chen L
Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of SOX7 induces cell proliferation and invasion and correlates with poor prognosis in oral squamous cell carcinoma.
Oh KY; Hong KO; Huh YS; Lee JI; Hong SD
J Oral Pathol Med; 2017 Oct; 46(9):752-758. PubMed ID: 28266739
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-494-3p Promotes Cell Growth, Migration, and Invasion of Nasopharyngeal Carcinoma by Targeting Sox7.
He H; Liao X; Yang Q; Liu Y; Peng Y; Zhong H; Yang J; Zhang H; Yu Z; Zuo Y; Guan C; Xu Z
Technol Cancer Res Treat; 2018 Jan; 17():1533033818809993. PubMed ID: 30381030
[TBL] [Abstract][Full Text] [Related]
6. Methylation of the CpG island near SOX7 gene promoter is correlated with the poor prognosis of patients with myelodysplastic syndrome.
Fan R; Zhang LY; Wang H; Yang B; Han T; Zhao XL; Wang W; Wang XQ; Lin GW
Tohoku J Exp Med; 2012 Jun; 227(2):119-28. PubMed ID: 22706399
[TBL] [Abstract][Full Text] [Related]
7. SOX7 methylation is an independent prognostic factor in myelodysplastic syndromes.
Xu ZJ; Tang CY; Zhou JD; Ma JC; Wen XM; Deng ZQ; Leng JY; Qiu ZY; Qian J; Lin J
Pathol Res Pract; 2019 Feb; 215(2):322-328. PubMed ID: 30554866
[TBL] [Abstract][Full Text] [Related]
8. SOX7 is associated with the suppression of human glioma by HMG-box dependent regulation of Wnt/β-catenin signaling.
Zhao T; Yang H; Tian Y; Xie Q; Lu Y; Wang Y; Su N; Dong B; Liu X; Wang C; Jiang C; Liu X
Cancer Lett; 2016 May; 375(1):100-107. PubMed ID: 26944317
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR-664 is associated with enhanced osteosarcoma cell migration and invasion ability via targeting SOX7.
Bao Y; Chen B; Wu Q; Hu K; Xi X; Zhu W; Zhong X; Chen J
Clin Exp Med; 2017 Feb; 17(1):51-58. PubMed ID: 26515813
[TBL] [Abstract][Full Text] [Related]
10. Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality.
Kim IK; Kim K; Lee E; Oh DS; Park CS; Park S; Yang JM; Kim JH; Kim HS; Shima DT; Kim JH; Hong SH; Cho YH; Kim YH; Park JB; Koh GY; Ju YS; Lee HK; Lee S; Kim I
J Exp Med; 2018 Mar; 215(3):963-983. PubMed ID: 29444818
[TBL] [Abstract][Full Text] [Related]
11. SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: both expressed at low levels in breast cancer.
Liu H; Mastriani E; Yan ZQ; Yin SY; Zeng Z; Wang H; Li QH; Liu HY; Wang X; Bao HX; Zhou YJ; Kou JJ; Li D; Li T; Liu J; Liu Y; Yin L; Qiu L; Gong L; Liu SL
Sci Rep; 2016 May; 6():26136. PubMed ID: 27188720
[TBL] [Abstract][Full Text] [Related]
12. MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7.
Han L; Wang W; Ding W; Zhang L
J Cell Mol Med; 2017 Sep; 21(9):2000-2008. PubMed ID: 28266181
[TBL] [Abstract][Full Text] [Related]
13. Expression of human SOX7 in normal tissues and tumors.
Katoh M
Int J Mol Med; 2002 Apr; 9(4):363-8. PubMed ID: 11891528
[TBL] [Abstract][Full Text] [Related]
14. miR-935 promotes gastric cancer cell proliferation by targeting SOX7.
Yang M; Cui G; Ding M; Yang W; Liu Y; Dai D; Chen L
Biomed Pharmacother; 2016 Apr; 79():153-8. PubMed ID: 27044823
[TBL] [Abstract][Full Text] [Related]
15. SOX7 Target Genes and Their Contribution to Its Tumor Suppressive Function.
Zhang Y; Stovall DB; Wan M; Zhang Q; Chou JW; Li D; Sui G
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757932
[TBL] [Abstract][Full Text] [Related]
16. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.
Shen F; Cai WS; Feng Z; Li JL; Chen JW; Cao J; Xu B
Tumour Biol; 2015 Mar; 36(3):1913-21. PubMed ID: 25407488
[TBL] [Abstract][Full Text] [Related]
17. Classic SRY-box protein SOX7 functions as a tumor suppressor regulating WNT signaling and is methylated in renal cell carcinoma.
Wang L; Fan Y; Zhang L; Li L; Kuang G; Luo C; Li C; Xiang T; Tao Q; Zhang Q; Ying J
FASEB J; 2019 Jan; 33(1):254-263. PubMed ID: 29957056
[TBL] [Abstract][Full Text] [Related]
18. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
[TBL] [Abstract][Full Text] [Related]
19. [The relationship and clinicopathological significance of Numb,MDM2 and p53 expression in human pancreatic cancer].
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):675-81. PubMed ID: 25410780
[TBL] [Abstract][Full Text] [Related]
20. Expression profile and prognostic value of NNMT in patients with pancreatic cancer.
Xu Y; Liu P; Zheng DH; Wu N; Zhu L; Xing C; Zhu J
Oncotarget; 2016 Apr; 7(15):19975-81. PubMed ID: 26942567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
